Foscarnet Sodium

• Recruiting NCT NCT03481881

  Pharmacokinetics of Drugs Administered to Children

  Duke University 200 participants Est. completion 2033-08-14 1 site
  Other conditions: Pediatric ALL
  View official trial listing →
• Recruiting NCT NCT06555432

  A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

  Takeda 168 participants Est. completion 2028-10-01 1 site
  Other conditions: Cytomegalovirus (CMV)
  View official trial listing →
• Recruiting NCT NCT07488728

  Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis

  Not yet reported Beijing Children's Hospital 80 participants Est. completion 2026-12-31 1 site
  Other conditions: EBV-associated T/NK-cell Lymphoproliferative Diseases, Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis, Letermovir
  View official trial listing →
• Recruiting NCT NCT07688759

  CMV-CMI in csCMVi After HSCT

  The First Affiliated Hospital of Soochow University 40 participants Est. completion 2028-08-31 1 site
  Other conditions: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation (HSCT), Immune Reconstitution
  View official trial listing →
• Completed NCT NCT00000134

  Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)

  Not yet reported Johns Hopkins Bloomberg School of Public Health 279 participants Est. completion 1995-03
  Other conditions: HIV Infections, Acquired Immunodeficiency Syndrome, Cytomegalovirus Retinitis
  View official trial listing →
• Completed NCT NCT00000136

  Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)

  Not yet reported Johns Hopkins Bloomberg School of Public Health 234 participants Est. completion 1991-10
  Other conditions: HIV Infections, Cytomegalovirus Retinitis
  View official trial listing →
• Completed NCT NCT00000665

  Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 240 participants 9 sites
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00000691

  A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 156 participants Est. completion 1992-08 11 sites
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Withdrawn NCT NCT00000697

  A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID)
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00000726

  Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 53 participants Est. completion 1992-02 5 sites
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00000729

  A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 1992-06 11 sites
  Other conditions: HIV Infections
  View official trial listing →
• Completed NCT NCT00000766

  CMV Retinitis Retreatment Trial

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 300 participants 9 sites
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Withdrawn NCT NCT00000856

  A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID)
  Other conditions: Encephalopathy, HIV Infections, Radiculitis
  View official trial listing →
• Completed NCT NCT00000964

  The Effect of Stomach Acid on Foscarnet

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 6 participants Est. completion 1990-10 1 site
  Other conditions: HIV Infections
  View official trial listing →
• Completed NCT NCT00000970

  A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 30 participants Est. completion 1993-06 6 sites
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00000985

  Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 26 participants Est. completion 1990-10 4 sites
  Other conditions: Herpes Simplex, HIV Infections
  View official trial listing →
• Completed NCT NCT00001002

  A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 12 participants Est. completion 1991-06 2 sites
  Other conditions: HIV Infections
  View official trial listing →
• Completed NCT NCT00001061

  Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 167 participants Est. completion 1998-03 20 sites
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00002021

  An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

  Not yet reported Astra USA 2 sites
  Other conditions: Herpes Simplex, HIV Infections
  View official trial listing →
• Completed NCT NCT00002039

  An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients

  Not yet reported Astra USA 1 site
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00002125

  A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)

  Not yet reported Astra USA 112 participants 11 sites
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00002144

  The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment

  Not yet reported Astra USA 12 participants 8 sites
  Other conditions: Herpes Simplex, HIV Infections
  View official trial listing →
• Completed NCT NCT00002145

  Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease

  Not yet reported Astra USA 145 participants 15 sites
  Other conditions: HIV Infections, Gastrointestinal Diseases
  View official trial listing →
• Completed NCT NCT00002146

  Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study

  Not yet reported Astra USA 12 participants 1 site
  Other conditions: Cytomegalovirus Infections, HIV Infections, Hypocalcemia
  View official trial listing →
• Completed NCT NCT00002272

  An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

  Not yet reported Astra USA 1 site
  Other conditions: Herpes Simplex, HIV Infections
  View official trial listing →
• Status unknown NCT NCT00002301

  A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir

  Not yet reported Astra USA 1 site
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00002432

  A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

  Not yet reported Astra USA 1 site
  Other conditions: Cytomegalovirus Retinitis, HIV Infections
  View official trial listing →
• Completed NCT NCT00947141

  Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

  Not yet reported University College, London 165 participants Est. completion 2013-02 1 site
  Other conditions: Viraemia
  View official trial listing →
• Status unknown NCT NCT00986557

  T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant

  Not yet reported University Hospital Birmingham 78 participants 1 site
  Other conditions: Graft Versus Host Disease, Nonneoplastic Condition
  View official trial listing →
• Completed NCT NCT01077908

  Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

  Not yet reported Cell Medica Ltd 89 participants Est. completion 2014-10 14 sites
  Other conditions: Cytomegalovirus Infection
  View official trial listing →
• Active, not recruiting NCT NCT01199562

  Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

  City of Hope Medical Center 153 participants Est. completion 2026-12-01 1 site
  Obstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Aplastic Anemia, Atypical Chronic Myeloid Leukemia, BCR-ABL Negative, Blastic Phase Chronic Myelogenous Leukemia, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Cytomegalovirus Infection, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Splenic Marginal Zone Lymphoma, Stage 0 Chronic Lymphocytic Leukemia, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia
  View official trial listing →
• Completed NCT NCT01220895

  Alternate Donor Study of Pre-Emptive Cellular Therapy

  Not yet reported Cell Medica Ltd 52 participants Est. completion 2014-01 9 sites
  Other conditions: Cytomegalovirus Infection
  View official trial listing →
• Completed NCT NCT01611974

  Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients

  Not yet reported Shire 120 participants Est. completion 2014-12-05 32 sites
  Other conditions: Cytomegalovirus (CMV)
  View official trial listing →
• Completed NCT NCT02151240

  Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster

  Not yet reported Cttq 94 participants Est. completion 2019-07 1 site Stand-alone
  Other conditions: Herpes Zoster
  View official trial listing →
• Completed NCT NCT02931539

  Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir

  Not yet reported Shire 352 participants Est. completion 2020-08-17 134 sites
  Other conditions: Cytomegalovirus (CMV)
  View official trial listing →
• Completed NCT NCT03004261

  CMV-CTL for the Treatment of CMV Infection After HSCT

  Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5 participants Est. completion 2021-12-31 1 site
  Other conditions: Cytomegalovirus Infections, Hematological Disease
  View official trial listing →
• Completed NCT NCT03073967

  Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

  Not yet reported AiCuris Anti-infective Cures AG 158 participants Est. completion 2025-11-11 70 sites
  Other conditions: HSV Infection
  View official trial listing →
• Terminated NCT NCT05370976

  Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.

  Not yet reported University Hospital, Lille 2 participants Est. completion 2023-08-24 1 site
  Other conditions: Cytomegalovirus Infections
  View official trial listing →
• Completed NCT NCT06439342

  A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

  Not yet reported Takeda 20 participants Est. completion 2026-07-22 11 sites
  Other conditions: Cytomegalovirus (CMV)
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT01199562

Also known as: Foscarnet Sodium, Foscavir, trisodium phosphonoformate

No related coverage yet.